Alexander T. AuWerter

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

Amit N. Patel, G. Ewald, M. Farr, 2015, European heart journal.